Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...

HDL cholesterol levels demonstrate a U-shaped association with AMD, in which both high and low levels elevate risk.

Faricimab should be readministered with caution in patients who develop mild intraocular inflammation with a previous dose of ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Telomir Pharmaceuticals (NASDAQ:TELO) on Tuesday announced results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines. Telomir ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE® (pegcetacoplan) for ...

Broadwood Partners, L.P., a significant stakeholder in Lineage Cell Therapeutics, Inc. (NYSE:LCTX), has acquired a ...

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $945.56, a high ...

Australia's Therapeutic Goods Administration has approved the use of a new and first treatment for geographic atrophy - a disease which causes severe ...

Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the US Patent Office (USPTO) has granted Active Biotech's US patent application 17/939,109 for laquinimod in eye disorders. "We ...

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at ...